Tnf Pharmaceuticals, Stock Price Prediction
| TNFA Stock | 1.36 0.11 7.48% |
Oversold Vs Overbought
62
Oversold | Overbought |
Using TNF Pharmaceuticals, hype-based prediction, you can estimate the value of TNF Pharmaceuticals, from the perspective of TNF Pharmaceuticals, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in TNF Pharmaceuticals, to buy its stock at a price that has no basis in reality. In that case, they are not buying TNF because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TNF Pharmaceuticals, after-hype prediction price | USD 1.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TNF |
TNF Pharmaceuticals, After-Hype Price Prediction Density Analysis
As far as predicting the price of TNF Pharmaceuticals, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TNF Pharmaceuticals, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TNF Pharmaceuticals,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TNF Pharmaceuticals, Estimiated After-Hype Price Volatility
In the context of predicting TNF Pharmaceuticals,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TNF Pharmaceuticals,'s historical news coverage. TNF Pharmaceuticals,'s after-hype downside and upside margins for the prediction period are 0.07 and 9.37, respectively. We have considered TNF Pharmaceuticals,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TNF Pharmaceuticals, is abnormally volatile at this time. Analysis and calculation of next after-hype price of TNF Pharmaceuticals, is based on 3 months time horizon.
TNF Pharmaceuticals, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as TNF Pharmaceuticals, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TNF Pharmaceuticals, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TNF Pharmaceuticals,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 7.97 | 0.02 | 0.02 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.36 | 1.34 | 1.47 |
|
TNF Pharmaceuticals, Hype Timeline
TNF Pharmaceuticals, is at this time traded for 1.36. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.02. TNF is forecasted to decline in value after the next headline, with the price expected to drop to 1.34. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.47%, whereas the daily expected return is at this time at 0.34%. The volatility of related hype on TNF Pharmaceuticals, is about 17711.11%, with the expected price after the next announcement by competition of 1.34. About 40.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TNF Pharmaceuticals, recorded a loss per share of 10.48. The entity last dividend was issued on the 25th of November 2019. The firm had 1:30 split on the 15th of February 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out TNF Pharmaceuticals, Basic Forecasting Models to cross-verify your projections.TNF Pharmaceuticals, Related Hype Analysis
Having access to credible news sources related to TNF Pharmaceuticals,'s direct competition is more important than ever and may enhance your ability to predict TNF Pharmaceuticals,'s future price movements. Getting to know how TNF Pharmaceuticals,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TNF Pharmaceuticals, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORIC | Oric Pharmaceuticals | 0.21 | 9 per month | 0.00 | (0.11) | 5.15 | (5.92) | 20.53 | |
| LYRA | Lyra Therapeutics | 0.01 | 4 per month | 0.00 | (0.07) | 10.53 | (10.00) | 41.07 | |
| INBX | Inhibrx | (0.23) | 5 per month | 0.00 | (0.1) | 4.72 | (4.90) | 11.96 | |
| EPIX | ESSA Pharma | 0.1 | 6 per month | 0.00 | (0.12) | 5.37 | (5.90) | 84.25 | |
| SNSE | Sensei Biotherapeutics | (0.04) | 3 per month | 7.52 | 0.04 | 11.11 | (13.21) | 110.76 | |
| NXTC | NextCure | (0.05) | 5 per month | 0.00 | (0.14) | 5.43 | (7.75) | 24.13 | |
| NUVB | Nuvation Bio | 0.04 | 10 per month | 0.00 | (0.02) | 9.48 | (8.36) | 21.30 | |
| GLUE | Monte Rosa Therapeutics | (0.83) | 10 per month | 4.59 | 0.05 | 8.40 | (8.46) | 103.72 | |
| DSGN | Design Therapeutics | 0.55 | 4 per month | 5.91 | 0.04 | 8.54 | (8.80) | 33.11 | |
| ERAS | Erasca Inc | (0.21) | 7 per month | 0.00 | (0.04) | 7.42 | (6.08) | 20.29 |
TNF Pharmaceuticals, Additional Predictive Modules
Most predictive techniques to examine TNF price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TNF using various technical indicators. When you analyze TNF charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TNF Pharmaceuticals, Predictive Indicators
The successful prediction of TNF Pharmaceuticals, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TNF Pharmaceuticals,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TNF Pharmaceuticals, based on analysis of TNF Pharmaceuticals, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TNF Pharmaceuticals,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TNF Pharmaceuticals,'s related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.57 | 0.54 | Price To Sales Ratio | 0.007865 | 0.008258 |
Story Coverage note for TNF Pharmaceuticals,
The number of cover stories for TNF Pharmaceuticals, depends on current market conditions and TNF Pharmaceuticals,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TNF Pharmaceuticals, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TNF Pharmaceuticals,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
TNF Pharmaceuticals, Short Properties
TNF Pharmaceuticals,'s future price predictability will typically decrease when TNF Pharmaceuticals,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TNF Pharmaceuticals, often depends not only on the future outlook of the potential TNF Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TNF Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 4.9 M |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |